BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37632137)

  • 1. An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma.
    Yang C; Cao F; He Y
    Med Sci Monit; 2023 Aug; 29():e940157. PubMed ID: 37632137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
    Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
    Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.
    Xu T; Dai T; Zeng P; Guo Y; He K
    Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer.
    Xie Y; Fu R; Xiao Z; Li G
    Pathol Oncol Res; 2022; 28():1610030. PubMed ID: 35356506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of autophagy-related genes in esophageal adenocarcinoma.
    Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
    BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
    Kang H; Wang N; Wang X; Zhang Y; Lin S; Mao G; Liu D; Dang C; Zhou Z
    Aging (Albany NY); 2020 Nov; 12(24):25828-25844. PubMed ID: 33234735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a prognostic signature of patients with esophagus adenocarcinoma by using immune-related genes.
    Zhang X; Yang L; Kong M; Ma J; Wei Y
    BMC Bioinformatics; 2021 Nov; 22(1):536. PubMed ID: 34724890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell exhaustion: A potential target biomarker of the tumour microenvironment affecting oesophageal adenocarcinoma.
    Peng S; Han X; Geng W; Zhao L
    J Gene Med; 2023 Jul; 25(7):e3496. PubMed ID: 36879295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.
    Mo BY; Li GS; Huang SN; Wei ZX; Su YS; Dai WB; Ruan L
    Med Sci Monit; 2020 Dec; 26():e928185. PubMed ID: 33361747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
    Lan T; Liu W; Lu Y; Luo H
    Medicine (Baltimore); 2021 Apr; 100(14):e25305. PubMed ID: 33832101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes.
    Duan L; Cao L; Zhang R; Niu L; Yang W; Feng W; Zhou W; Chen J; Wang X; Li Y; Zhang Y; Liu J; Zhao Q; Fan D; Hong L
    Bioengineered; 2021 Dec; 12(1):3434-3454. PubMed ID: 34252349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
    Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
    J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes associated with esophageal adenocarcinoma based on bioinformatics analysis.
    Qi W; Li R; Li L; Li S; Zhang H; Tian H
    Ann Transl Med; 2021 Dec; 9(23):1711. PubMed ID: 35071405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.
    Xu T; Yuan Y; He C; Yang K
    Med Sci Monit; 2021 Jan; 27():e927850. PubMed ID: 33510126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 16. Multivariate gene expression-based survival predictor model in esophageal adenocarcinoma.
    Zhao M; Wang J; Yuan M; Ma Z; Bao Y; Hui Z
    Thorac Cancer; 2020 Oct; 11(10):2896-2908. PubMed ID: 32869505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
    Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
    Front Oncol; 2021; 11():766072. PubMed ID: 34868990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma.
    Zhu L; Yang F; Wang L; Dong L; Huang Z; Wang G; Chen G; Li Q
    Cancer Cell Int; 2021 Feb; 21(1):124. PubMed ID: 33602233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.